首页> 外文期刊>Transplantation Proceedings >Recurrence rate and transplantability after liver resection in patients with hepatocellular carcinoma who initially met transplantation criteria.
【24h】

Recurrence rate and transplantability after liver resection in patients with hepatocellular carcinoma who initially met transplantation criteria.

机译:最初符合移植标准的肝细胞癌患者肝切除后的复发率和可移植性。

获取原文
获取原文并翻译 | 示例
           

摘要

To understand the recurrence rate and transplantability after liver resection (LR), which are essential factors to predict the prognosis of initial resection and salvage transplantation for hepatocellular carcinoma (HCC), we reviewed the clinical records of 279 consecutive HCC patients who met the Milan criteria and underwent LR between 1990 and 2000. Recurrence-free survival rates after 1, 2, 3, 5, and 10 years following LR were 84%, 62%, 49%, 29%, and 17%, respectively. Multivariate analysis using clinical factors such as age, sex, histological differentiation, serum levels of alpha-fetoprotein and 7S domain of type IV collagen (7S collagen), platelet counts, indocyanin green retention test after 15 minutes, and type of LR (resection of one or more segments, or less than one segment) revealed 7S collagen to be a independent factor that significantly affects recurrence-free survival. Yearly recurrence rates up to 5 years after resection ranged from 14% to 27%, averaging 20%. Concerning 169 patients who underwent tests for 7S collagen, the average yearly recurrence rate (27%) in patients with 7S collagen levels 8.0 ng/mL or higher was remarkably greater than that in the patients with levels less than 8.0 ng/mL (16%). The transplantability rate at the time of recurrence meeting the Milan criteria was roughly 60%. There were no pre-LR factors that significantly predicted transplantability. This result indicates that patients with lower 7S collagen levels are more eligible for initial LR and then salvage LT rather than primary LT.
机译:为了了解肝切除术(LR)的复发率和可移植性,这些是预测肝癌(HCC)初次切除和抢救移植预后的重要因素,我们回顾了符合Milan标准的279例连续HCC患者的临床记录并在1990年至2000年间接受LR。在LR发生1、2、3、5和10年后,无复发生存率分别为84%,62%,49%,29%和17%。使用临床因素进行多变量分析,例如年龄,性别,组织学分化,血清甲胎蛋白水平和IV型胶原蛋白(7S胶原蛋白)的7S结构域,血小板计数,15分钟后吲哚青绿保留试验和LR类型(切除一个或多个区段,或少于一个区段)显示7S胶原蛋白是独立因素,会显着影响无复发生存率。切除后长达5年的年复发率介于14%至27%之间,平均为20%。对于169位接受7S胶原蛋白检测的患者,7S胶原蛋白水平为8.0 ng / mL或更高的患者的年平均复发率(27%)显着高于水平低于8.0 ng / mL的患者(16% )。达到米兰标准的复发时的可移植率约为60%。没有LR前因子可显着预测可移植性。该结果表明,具有较低7S胶原蛋白水平的患者更适合于初次LR,然后挽救LT,而不是原发性LT。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号